Now I have all the information I need. Let me construct the final review carefully.

## Summary
After thoroughly reading the paper and cross-referencing every reviewer claim, here is my consolidated assessment.

The paper makes two contributions: (1) a systematic benchmark of LLMs (GPT-4o, GPT-o3, GPT-5, Gemini variants) for Gene Ontology Biological Process prediction on curated gene sets (Stage 1), and (2) a framework that uses LLM-generated GO annotations to compute intra-cluster agreement (ICS) and inter-cluster distinctiveness (ICD), combined into a Resolution Score for selecting clustering granularity, applied to one K562 CRISPRi Perturb-seq dataset (Stage 2). The Stage 1 benchmark is solid and provides useful evidence about which LLMs and prompts work best for GO annotation. However, the Stage 2 claim — that the Resolution Score selects biologically superior clusterings compared to classical metrics — is not convincingly validated. The evaluation lacks an external biological ground truth, the enrichment analysis presented as validation has a contradiction (the score peaks at r=0.7, not at the claimed 0.4/0.5), and the baselines are compared without demonstrating superiority.

Now I will apply the filtering discipline strictly before writing.

**Filtering the Harsh Critic's points:**

1. **"No validated ground truth for resolution selection"** — RETAIN as Major. The abstract states "alignment with known pathway" but no known-pathway comparison is carried out. The enrichment analysis is used as validation but has issues (see below). The paper's central claim about superior biological interpretability lacks the necessary quantitative grounding.

2. **"Potential circularity between annotation and scoring"** — RETAIN as Minor. Valid concern. However, the Stage 1 benchmark does validate annotation accuracy on curated sets, and the enrichment analysis provides a partially independent check. The concern is real but not fatal. A spot-check on actual cluster signatures would strengthen the paper.

3a. **"Comparison with baselines is weak... No evidence that the latter is biologically superior"** — RETAIN as Major. The paper shows silhouette (0.5-0.6) and modularity (0.7) choose different resolutions but never demonstrates its choice (0.4) is better. This is a core gap.

3b. **"Functional enrichment analysis... yields the same optimal resolutions... undermines the claim of superiority"** — REMOVE this specific framing. The critic misreads this section. The enrichment analysis is presented as *validation*, not as a baseline. However, there is a more serious problem the critic missed: the *paper's own figure caption* (Figure 6) says the enrichment-based Resolution Score "peaks at 0.7," not at 0.4/0.5. The text then appeals to "reasonability of cluster numbers" to select 0.4/0.5. This contradiction means the enrichment analysis does not actually validate the LLM's choice — a problem worse than what the critic described. I'll include this as a separate major weakness.

4. **"Single-dataset evaluation limits generalizability"** — RETAIN as Major. Valid. One dataset is insufficient for the scope of claims made.

**Other harsh critic points:**
- w=1/3 "small grid search" with no details — RETAIN as Minor. The paper mentions Figure S5 tests w, but the sensitivity of the optimal resolution to w is not discussed.
- "Statistical significance or variance of the Resolution Score" — REMOVE. The paper shows box plots which already show distribution. Bootstrapping would be nice but not standard.
- "Computational cost comparison" — RETAIN as Trivial. The paper claims "orders of magnitude faster than manual curation" without data.
- "Discussion of failure modes" — RETAIN as Nice-to-Have. Valid suggestion but not a core weakness.

**Filtering the Strength Finder's points:**

**Strength 1:** "Resolution Score identifies biologically meaningful granularities" — WEAKEN. The enrichment analysis validation is problematic (see Figure 6 caption vs. text). The UMAP is not strong evidence. The agreement with enrichment is partially circular (same ICS/ICD framework). I'll downgrade this to a supporting strength: the method produces *consistent* results with enrichment analysis (modulo the peak discrepancy) and selects a resolution that produces visually coherent clusters.

**Strength 2:** "LLM agent produces accurate, self-ranked GO hypotheses" — KEEP as a genuine strength. Well-supported by Stage 1 data.

**Strength 3:** "Agent-based score aligns with biological knowledge better than classical metrics" — REMOVE or significantly weaken. The evidence for "better" is not provided. The paper shows different resolutions are chosen but doesn't prove the method's choice is better.

**Supporting strengths (ablation, formal definitions, automation):** KEEP all three. These are genuine contributions.

Now let me write the review.

Actually, wait. I need to check the Strength Finder more carefully. It says:

"1. **The Resolution Score identifies biologically meaningful granularities on Perturb-seq data.**
   ... confirmed by functional‑enrichment analysis, which also peaks at r=0.4–0.5 when the same ICS/ICD metrics are applied to the enrichment results (Fig. 6 and Sec. 4.4.3)."

But the figure caption says the enrichment-based score peaks at 0.7, not 0.4-0.5. The strength finder is repeating the paper's text claim without noticing the figure caption discrepancy. So this strength is based on an incorrect reading of the evidence. I should REMOVE this strength.

Let me also check: does the strength finder say "peaks at r=0.4–0.5"? Yes it does. But the figure caption says "peaks at 0.7." This is a significant discrepancy that I should flag.

Let me finalize my review structure:

**Summary**: 2-3 sentences
**Strengths**: 3-4 concrete strengths
**Weaknesses**: 
- Fatal: None
- Major: 3-4 points
- Minor: 2-3 points
- Trivial: 1-2 points
**Nice-to-Haves**: 2-3 suggestions
**Removed Points**: Points from reviewers that I removed with justification
**Novel Insights**: Brief synthesis
**Suggestions**: Actionable recommendations
**Score and Decision**

Let me write it now.## Summary

HypoGeneAgent proposes an LLM-driven framework that generates ranked GO hypotheses for gene-set clusters and combines intra-cluster agreement (ICS) and inter-cluster distinctiveness (ICD) into a Resolution Score for selecting clustering granularity in single-cell/Perturb-seq data. The paper has two components: a systematic Stage 1 benchmark of LLMs for GO annotation on curated GOBP gene sets (well-executed), and a Stage 2 application on one K562 Perturb-seq dataset where the Resolution Score is used to choose a Leiden resolution. The Stage 1 benchmark provides useful evidence about LLM capabilities for GO annotation, but the central Stage 2 claim — that the method selects biologically superior clusterings compared with classical metrics — is not convincingly validated due to the absence of external biological ground truth, an enrichment "validation" that contains an unresolved contradiction, and baseline comparisons that show differences but not which choice is better.

## Strengths

1. **Well-executed Stage 1 benchmark of LLMs for GO annotation.** On 100 curated GOBP gene sets, the paper systematically compares five LLM backbones, three embedding methods, two prompt designs, and temperature settings. GPT-o3 with the hypothesis prompt achieves the highest median cosine similarity to ground-truth GO terms, and its confidence scores correlate well with semantic similarity (Figs. S1d, S3). This is a solid empirical contribution that provides grounded recommendations for practitioners using LLMs for gene-set annotation.

2. **Formal definition of annotation-consistency metrics.** The paper gives clear formulas for ICS (intra-cluster agreement), ICD (inter-cluster distinctiveness), and the combined Resolution Score (Table 1, Section 3.4). These are principled quantities that operationalize the intuitive notion that a good clustering should yield both internally coherent and mutually exclusive functional interpretations.

3. **Integration of automated annotation with resolution selection into a single pipeline.** The same LLM output that produces GO hypotheses for each cluster also drives the resolution-scoring metrics, eliminating the need for manual marker-gene inspection at the resolution-tuning step. This is a novel framing that connects two traditionally separate stages of single-cell analysis.

4. **Systematic ablation of prompt designs and LLM backbones.** The comparison between general-analysis prompts and hypothesis prompts across thinking and non-thinking LLMs (Figs. S1b, S1e) yields actionable insights — e.g., that thinking LLMs (GPT-o3, Gemini‑2.5‑pro) benefit more consistently from improved prompting than non-thinking ones.

## Weaknesses

### Fatal
None.

### Major

1. **No external ground truth for resolution selection; core claim unvalidated.** The abstract and conclusion assert that the method selects clusterings that "exhibit alignment with known pathway" and "recover known perturbation effects better" than classical metrics. Yet the paper never quantifies the quality of the chosen resolution against any independent biological reference — no comparison with known perturbation functional groups, curated cell-type labels, marker-gene signatures, or any external gold standard. The only "validation" is the enrichment analysis (Section 4.4.3), which applies the **same ICS/ICD framework** to standard Fisher's-test GO terms. This approach is partially circular and, as detailed in Weakness 2, contains a contradiction that undermines its value as validation. Without a quantitative external benchmark (e.g., ARI/NMI against known perturbation groupings), the central claim that the method is *superior* to silhouette and modularity is not supported by evidence.

2. **The enrichment analysis (Section 4.4.3) contradicts the paper's validation narrative and raises a significant internal inconsistency.** The paper presents the enrichment analysis as validating the LLM-based Resolution Score's choice of r=0.4/0.5. However, **the paper's own figure caption for Figure 6 states that the enrichment-based Resolution Score "peaks at 0.7"** — not at 0.4/0.5. The main text then says "consider the reasonability of cluster numbers we expected, so the selected resolution can be 0.5 or 0.4." This means the enrichment-based ICS/ICD score does *not* actually agree with the LLM-based score; the authors must override the enrichment score's peak with a subjective judgment about cluster number reasonability. This is a critical inconsistency: either the enrichment analysis disagrees with the method (undermining the validation claim), or the objective score is being adjusted post hoc (undermining the objectivity claim). This discrepancy must be resolved before the validation argument holds.

3. **Baseline comparisons do not demonstrate superiority; only differences are shown.** The paper reports that silhouette score chooses r=0.5–0.6 and modularity chooses r=0.7, while HypoGeneAgent chooses r=0.4 (GEX) and r=0.5 (perturbations). These are modest differences (one or two steps in the 0.1–1.0 grid). The paper provides *no evidence whatsoever* that the method's choice is biologically superior — no quantitative metric (e.g., enrichment significance, pathway-recovery rate, NMI with known groups) is compared across the different resolutions selected by each method. Showing that different methods pick different resolutions is not the same as showing that one is better.

4. **Single-dataset evaluation.** Stage 2 is conducted on exactly one dataset (K562 CRISPRi Perturb-seq from Replogle et al. 2022). The abstract and conclusion make broad claims ("readily extends to multi-omics modalities," "general-purpose tool"), but no second dataset, modality, or system is tested. Even within the Perturb-seq setting, robustness across different cell types, perturbation libraries, or sequencing technologies is not shown. A single "preliminary test" (as the abstract qualifies it) cannot support the level of generality claimed.

### Minor

5. **Partial circularity in the Resolution Score.** The score is computed from the LLM's own hypotheses, so a high score could reflect self-consistent (but factually incorrect) annotations rather than true biological coherence. Stage 1 validates annotation accuracy on curated GOBP sets, but these are clean reference sets, not the noisier cluster signatures from the Perturb-seq data. A spot-check comparing LLM annotations on actual cluster signatures against standard GO enrichment results (e.g., Jaccard on top GO IDs) would strengthen the paper.

6. **Limited sensitivity analysis for the weighting parameter \(w\) and hypothesis count \(H\).** The paper uses \(w=1/3\) and \(H=5\) with brief justification. Figure S5 reportedly tests \(w\) sensitivity, but the paper does not discuss whether the *optimal resolution* changes across reasonable values of \(w\). If the chosen resolution is sensitive to \(w\), the method's objectivity claim weakens.

7. **Unexplained selection of r=0.4 vs. r=0.5 between GEX and perturbation levels.** The method selects r=0.4 for gene-expression clusters and r=0.5 for perturbation clusters. The paper does not discuss whether this discrepancy is expected or what it implies about the method's consistency across data modalities within the same experiment.

### Trivial

8. **The claim "orders of magnitude faster than manual curation" (Conclusion) is made without any runtime or cost data.** Given the expense of GPT-o3 inference, this claim needs support.

9. **The phrase "recover known perturbation effects better" (Introduction) is used without specifying which known effects or how recovery is measured.**

## Nice-to-Haves

- **External validation using known groupings in the K562 data.** The Replogle et al. dataset has perturbations targeting known pathways. Computing the overlap (ARI/NMI) between cluster assignments at each resolution and predefined functional groups would provide a direct, independent validation of whether r=0.4/0.5 truly recovers known biology better than alternatives.
- **Ablation: standard enrichment-based ICS/ICD vs. LLM-based ICS/ICD.** Apply the same ICS/ICD metrics to standard Fisher's-test GO terms across all resolutions, and directly compare the score curves and selected resolutions with the LLM-based version. This would clarify whether the LLM adds unique signal or whether the ICS/ICD framework alone (regardless of annotation source) drives the result.
- **Confidence intervals on the optimal resolution** (e.g., via bootstrapping clusters or genes) to assess the stability of the selection.
- **A second dataset** from a different cell type or perturbation modality to demonstrate generalizability.

## Removed Points

These points were flagged by the reviewers but removed or merged after cross-checking against the paper, with justification:

- **"Functional enrichment analysis yields the same optimal resolutions (0.4–0.5) as the LLM pipeline, undermining the claim of superiority"** (Harsh Critic Point 3b, in its original framing). *Removed because this misreads the paper: the enrichment analysis is presented as validation, not as a baseline comparison. However, I surfaced an even more serious issue — the figure caption actually says the enrichment score peaks at 0.7, not 0.4/0.5 — which is handled in Major Weakness 2.*
- **"Statistical significance or variance of the Resolution Score across resolutions"** (Harsh Critic, Missing Parts). *Removed because the paper provides box plots showing distributions, which is standard for this type of analysis. Bootstrapping is a nice-to-have, not a missing requirement.*
- **"Potential hallucination leading to high Resolution Score for wrong clusters"** (Harsh Critic, failure modes). *Downgraded to Nice-to-Have. This is a generic concern applicable to any LLM-based pipeline and is not specific to this paper's methodology.*
- **Strengths Finder's claim that "the Resolution Score identifies biologically meaningful granularities… confirmed by functional enrichment analysis, which also peaks at r=0.4–0.5."** *Removed because the paper's own Figure 6 caption states the enrichment score peaks at 0.7, contradicting this claim. The strength is unsupported by the evidence as presented.*

## Novel Insights

The reviewers collectively surface a core tension that the paper does not resolve: the Resolution Score is simultaneously a tool for *selecting* a resolution and a metric that depends on the *quality* of LLM annotations. The paper validates annotation quality on curated sets but not on the actual cluster signatures, leaving a gap. The more novel insight is that this tension could be productively exploited — e.g., the LLM-derived score could flag resolutions where annotations are inconsistent as low-quality, which is a different and potentially more defensible use of the framework than claiming superiority over silhouette/modularity. The enrichment analysis contradiction (peaking at 0.7 in the figure but claimed as 0.4/0.5 in text) is an artifact that needs clarification before any insight can be drawn from that component.

## Suggestions

1. **Add an external validation experiment.** Use the known perturbation target groupings in the Replogle et al. K562 data (or another labeled reference) to compute the ARI or NMI between clusterings at each resolution and the ground-truth groups. Compare these scores for the resolutions chosen by HypoGeneAgent, silhouette, modularity, and enrichment-based ICS/ICD. This directly tests whether the method's choice better recovers known biology.

2. **Resolve the Figure 6 discrepancy.** Clarify whether the enrichment-based Resolution Score peaks at 0.7 (as the caption states) or at 0.4/0.5 (as the text claims). If it peaks at 0.7, explain why r=0.4/0.5 is still preferred and what "reasonability of cluster numbers" means quantitatively. If the caption is incorrect, correct it.

3. **Characterize the LLM's unique contribution.** Run the full pipeline replacing LLM-generated annotations with standard GO enrichment terms, and compare the selected resolutions. If they agree, the contribution is the ICS/ICD framework rather than the LLM component; if they disagree, demonstrate with external validation that the LLM-based choice is biologically better.

4. **Add at least one additional dataset** from a different cell type, perturbation modality, or species to demonstrate generalizability beyond K562.

5. **Provide runtime/cost estimates** for the LLM inference in Stage 2 to support claims about efficiency.

## Score and Decision

Based on the above assessment: the Stage 1 benchmark is a solid contribution, and the idea of using annotation consistency for resolution selection is novel and worth pursuing. However, the Stage 2 evaluation is insufficient to support the paper's central claims of superiority over classical metrics and alignment with known biology. The enrichment analysis, which is the primary validation, contains an internal contradiction (Figure 6 caption vs. text) that calls its conclusions into question. Baseline comparisons show differences but not which is better. The single-dataset design limits generalizability. The paper's strongest claims are not matched by the evidence.

A paper with this profile — a well-executed component (Stage 1) paired with an insufficiently validated central claim — merits a borderline score. The work would benefit substantially from additional validation experiments before it can be accepted.

MY FINAL SCORE: <score>4.5</score>
MY FINAL DECISION: <decision>Reject</decision>